Cytosorbents ROE 2007-2020 | CTSO

Current and historical return on equity (ROE) values for Cytosorbents (CTSO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Cytosorbents ROE for the three months ending March 31, 2020 was -165.86%.
Cytosorbents ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $-0.02B $0.02B -167.44%
2019-12-31 $-0.02B $0.00B -216.22%
2019-09-30 $-0.02B $0.01B -164.71%
2019-06-30 $-0.02B $0.01B -106.25%
2019-03-31 $-0.02B $0.02B -102.70%
2018-12-31 $-0.02B $0.02B -93.15%
2018-09-30 $-0.02B $0.02B -90.91%
2018-06-30 $-0.01B $0.02B -101.82%
2018-03-31 $-0.01B $0.01B -97.56%
2017-12-31 $-0.01B $0.01B -144.00%
2017-09-30 $-0.01B $0.01B -275.00%
2017-06-30 $-0.01B $0.01B -550.00%
2017-03-31 $-0.01B $-0.00B -1200.00%
2016-12-31 $-0.01B $0.00B -400.00%
2016-09-30 $-0.01B $0.00B -210.53%
2016-06-30 $-0.01B $0.00B -162.96%
2016-03-31 $-0.01B $0.01B -80.00%
2015-12-31 $-0.01B $0.01B -102.56%
2015-09-30 $-0.02B $0.01B -194.29%
2015-06-30 $-0.02B $0.01B -200.00%
2015-03-31 $-0.02B $0.01B -280.00%
2014-12-31 $-0.02B $0.00B -248.28%
2014-09-30 $-0.01B $0.01B -138.46%
2014-06-30 $-0.01B $0.01B -147.37%
2014-03-31 $-0.01B $0.01B -200.00%
2013-12-31 $-0.01B $0.00B -480.00%
2013-09-30 $-0.01B $0.00B -480.00%
2013-06-30 $-0.01B $0.00B -480.00%
2013-03-31 $-0.01B $0.00B -480.00%
2012-12-31 $-0.01B $0.00B -600.00%
2012-09-30 $-0.01B $0.00B -800.00%
2012-06-30 $-0.01B $0.00B -933.33%
2012-03-31 $-0.01B $0.00B -700.00%
2011-12-31 $-0.01B $0.00B -700.00%
2011-09-30 $-0.01B $0.00B -600.00%
2011-06-30 $-0.01B $0.00B -1000.00%
2011-03-31 $-0.00B $0.00B inf%
2010-12-31 $-0.00B $0.00B 1200.00%
2010-09-30 $-0.00B $-0.00B inf%
2010-06-30 $-0.00B $0.00B -1200.00%
2010-03-31 $-0.00B $0.00B -600.00%
2009-12-31 $-0.00B $0.00B -300.00%
2009-09-30 $-0.00B $0.00B -320.00%
2009-06-30 $-0.00B $0.00B -200.00%
2009-03-31 $-0.00B $0.00B -160.00%
2008-12-31 $-0.00B $0.00B -228.57%
2008-09-30 $-0.00B $0.00B -320.00%
2008-06-30 $-0.00B $0.00B -800.00%
2008-03-31 $-0.00B $-0.00B 1600.00%
2007-12-31 $-0.00B $0.00B -1600.00%
2007-06-30 $-0.00B $0.00B -240.00%
2007-03-31 $-0.01B $0.00B -400.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.369B $0.025B
CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.760B 28.40
Medtronic (MDT) Ireland $122.876B 19.96
Stryker (SYK) United States $68.133B 22.11
Boston Scientific (BSX) United States $48.348B 22.73
Baxter (BAX) United States $42.697B 26.06
Lonza Group Ag (LZAGY) Switzerland $42.097B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.300B 0.00
Terumo (TRUMY) Japan $28.368B 36.26
ResMed (RMD) United States $27.881B 44.00
Zimmer Biomet Holdings (ZBH) United States $24.546B 15.44
Sunny Optical Technology (SNPTF) China $20.292B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.095B 0.00
Bio-Rad Laboratories (BIO) United States $13.860B 63.09
Insulet (PODD) United States $13.102B 1298.06
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $9.974B 78.38
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
GN STORE NORD (GNNDY) Denmark $7.628B 38.88
Perrigo (PRGO) Ireland $7.488B 13.40
Hill-Rom Holdings (HRC) United States $7.452B 21.01
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.729B 0.00
Haemonetics (HAE) United States $4.502B 27.04
Neogen (NEOG) United States $4.099B 69.43
GW Pharmaceuticals (GWPH) United Kingdom $4.005B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.905B 0.00
ICU Medical (ICUI) United States $3.833B 27.96
Agios Pharmaceuticals (AGIO) United States $3.779B 0.00
Envista Holdings (NVST) United States $3.229B 0.00
NuVasive (NUVA) United States $2.788B 22.39
TG Therapeutics (TGTX) United States $2.629B 0.00
National Vision Holdings (EYE) United States $2.369B 40.99
AtriCure (ATRC) United States $1.744B 0.00
MacroGenics (MGNX) United States $1.548B 0.00
NanoString Technologies (NSTG) United States $1.417B 0.00
Aurora Cannabis (ACB) Canada $1.377B 0.00
Aphria (APHA) Canada $1.233B 0.00
Cerus (CERS) United States $1.159B 0.00
Cardiovascular Systems (CSII) United States $1.072B 0.00
Meridian Bioscience (VIVO) United States $1.049B 39.48
Phibro Animal Health (PAHC) United States $1.015B 20.24
Vapotherm (VAPO) United States $0.971B 0.00
PetIQ (PETQ) United States $0.948B 27.39
DFB Healthcare Acquisitions (AHCO) United States $0.919B 153.00
InMode (INMD) Israel $0.916B 19.36
Zynex (ZYXI) United States $0.875B 87.87
OraSure Technologies (OSUR) United States $0.830B 167.13
Quanterix (QTRX) United States $0.762B 0.00
Omeros (OMER) United States $0.757B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.634B 45.44
VAREX IMAGING (VREX) United States $0.580B 14.40
BioLife Solutions (BLFS) United States $0.574B 163.54
Lantheus Holdings (LNTH) United States $0.572B 11.50
Surmodics (SRDX) United States $0.571B 68.79
LeMaitre Vascular (LMAT) United States $0.528B 30.09
Owens & Minor (OMI) United States $0.486B 12.85
Viemed Healthcare (VMD) United States $0.406B 36.00
Neptune Wellness Solutions (NEPT) Canada $0.335B 0.00
Utah Medical Products (UTMD) United States $0.313B 22.73
HEXO (HEXO) $0.309B 0.00
Organigram Holdings (OGI) Canada $0.271B 0.00
InfuSystems Holdings (INFU) United States $0.223B 123.67
Female Health (VERU) United States $0.217B 0.00
Chimerix (CMRX) United States $0.193B 0.00
Surface Oncology (SURF) United States $0.176B 0.00
Bovie Medical (APYX) United States $0.164B 0.00
Exagen (XGN) United States $0.145B 0.00
Fonar (FONR) United States $0.136B 12.03
Rockwell Medical (RMTI) United States $0.127B 0.00
United Health Products (UEEC) United States $0.122B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.118B 0.00
Liberty Health Sciences (LHSIF) Canada $0.113B 0.00
Evolus (EOLS) United States $0.113B 0.00
Wound Management Technologies (SMTI) United States $0.105B 0.00
MTech Acquisition (KERN) United States $0.099B 0.00
Chembio Diagnostics (CEMI) United States $0.086B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.079B 0.00
Nephros (NEPH) United States $0.068B 0.00
Capricor Therapeutics (CAPR) United States $0.066B 0.00
United-Guardian (UG) United States $0.066B 15.31
Trinity Biotech (TRIB) Ireland $0.065B 0.00
Brainsway (BWAY) Israel $0.061B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
FSD PHARMA INC (HUGE) Canada $0.028B 0.00
NF Energy Saving (BIMI) China $0.020B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00